Terminal cancer patients in complete remission after one gene therapy treatment 

Terminal cancer patients in complete remission after one gene therapy treatment 

A groundbreaking gene therapy treatment which boosts a patient's own immune cells has been shown to clear disease from one third of terminal patients. US pharmaceutical company Kite Pharma released results from the first six months of its trial of the new treatment, called CAR-T cell therapy. Some 36 per cent of the 101 patients on the trial were still in complete remission at six months, and eight in 10 saw their cancer shrink by at least half during the study.

View Full Post

More great content like this @ Health & Body Front Page or you can Request Invite

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s